Concepedia

Luc Lucas

LL

Statistics

Publications

3

Citations

32

H-Index

3

Active since

2016

Affiliations

Slotervaartziekenhuis(Current)

The Netherlands Cancer Institute

Utrecht University

Astex Pharmaceuticals

Luc Lucas is an author at Slotervaartziekenhuis specializing in drug analysis, drug discovery, and pharmacotherapy.

Top concepts

Publications per year

2016–2019

3

Publications

3

Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine

Jeroen Roosendaal, Kai Wang, Hilde Rosing et al. · Journal of Chromatography B · 2019 · 12 citations · Full text

, , +9

Metabolite profiling of<sup>14</sup>C-omacetaxine mepesuccinate in plasma and excreta of cancer patients

Cynthia M. Nijenhuis, Luc Lucas, Hilde Rosing et al. · Xenobiotica · 2016 · 10 citations

Development, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of total intracellular β-decitabine nucleotides and genomic DNA incorporated β-decitabine and 5-methyl-2′-deoxycytidine

Jeroen Roosendaal, Hilde Rosing, Luc Lucas et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 10 citations · Full text

1–3 of 3